IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues
- 1 May 2004
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 4 (5) , 669-677
- https://doi.org/10.1016/j.intimp.2004.01.016
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Lack of gp130 expression in hepatocytes promotes liver injury1 1K.L.S. and T.W. contributed equally to this work.Gastroenterology, 2003
- TH1-TH2: a Procrustean paradigmNature Immunology, 2003
- Tissue Involution and the Acute Phase ResponseAnnals of the New York Academy of Sciences, 2003
- A Genome-Wide Analysis of the Acute-Phase Response and Its Regulation by Stat3βAnnals of the New York Academy of Sciences, 2003
- Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell LineJournal of Biological Chemistry, 2002
- Interleukin 24 (MDA-7/MOB-5) Signals through Two Heterodimeric Receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2Journal of Biological Chemistry, 2002
- Acinar Cells of the Pancreas Are a Target of Interleukin-22Journal of Interferon & Cytokine Research, 2001
- Interleukin 20Cell, 2001
- Identification of the Functional Interleukin-22 (IL-22) Receptor ComplexJournal of Biological Chemistry, 2001
- The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancyBlood Reviews, 2000